Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. en.wikipedia.org › wiki › Mark_MattsonMark Mattson - Wikipedia

    Mark P. Mattson is an American neuroscientist who is an adjunct professor of neuroscience at the Johns Hopkins School of Medicine.

  2. www.youtube.com › c › MarkMattsonPEMark Mattson - YouTube

    Videos related to civil engineering and technology topics.

  3. lifeapps.io › fasting-es › 5-estudios-de-ayuno-humano-con-el-dr-mark-mattson5 estudios de ayuno humano con el Dr. Mark Mattson

    28 de dic. de 2021 · El Dr. Mark Mattson, neurocientífico del Instituto Nacional sobre el Envejecimiento y profesor de neurociencia en la Universidad Johns Hopkins, estudia los mecanismos celulares y moleculares que subyacen a estos beneficios. Él compara el ayuno intermitente con el ejercicio; ambos son factores estresantes “buenos” que impulsan ...

  4. scholar.google.com › citations‪Mark P. Mattson‬ - ‪Google Scholar‬

    Mark P. Mattson. DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... S Oddo, A Caccamo, JD Shepherd, MP Murphy, TE Golde, R Kayed, ... A model for beta-amyloid...

  5. www.youtube.com › watchWhy fasting bolsters brain power: Mark Mattson at ... - YouTube

    18 de mar. de 2014 · Mark Mattson is the current Chief of the Laboratory of Neurosciences at the National Institute on Aging. He is also a professor of Neuroscience at The Johns Hopkins...

  6. www.hopkinsmedicine.org › news › newsroomIntermittent Fasting: Live ‘Fast,’ Live longer? | Johns Hopkins...

    26 de dic. de 2019 · But, does scientific evidence support the claims made for these diets? In a review article published in the Dec. 26 issue of The New England Journal of Medicine, Johns Hopkins Medicine neuroscientist Mark Mattson, Ph.D., concludes that intermittent fasting does.

  7. neuroscience.jhu.edu › research › facultyMark P. Mattson - The Solomon H Snyder Department of Neuroscience

    A multifaceted array of experimental models of aging and age-related neurodegenerative disorders are being employed in order to establish the molecular and biochemical changes that occur during aging and in disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and stroke.